Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1994 Sep;57(9):1138–1139. doi: 10.1136/jnnp.57.9.1138

Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects.

J M Goldstein, S G Waxman, T L Vollmer, B Lang, I Johnston, J Newsom-Davis
PMCID: PMC1073150  PMID: 8089692

Full text

PDF
1138

Images in this article

1138Image
on p.1138

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blumenfeld A. M., Recht L. D., Chad D. A., DeGirolami U., Griffin T., Jaeckle K. A. Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: differential effects of treatment. Neurology. 1991 Oct;41(10):1682–1685. doi: 10.1212/wnl.41.10.1682. [DOI] [PubMed] [Google Scholar]
  2. Clouston P. D., Saper C. B., Arbizu T., Johnston I., Lang B., Newsom-Davis J., Posner J. B. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology. 1992 Oct;42(10):1944–1950. doi: 10.1212/wnl.42.10.1944. [DOI] [PubMed] [Google Scholar]
  3. Cutler R. W., Watters G. V., Hammerstad J. P. The origin and turnover rates of cerebrospinal fluid albumin and gamma-globulin in man. J Neurol Sci. 1970 Mar;10(3):259–268. doi: 10.1016/0022-510x(70)90154-1. [DOI] [PubMed] [Google Scholar]
  4. Lang B., Newsom-Davis J., Prior C., Wray D. Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J Physiol. 1983 Nov;344:335–345. doi: 10.1113/jphysiol.1983.sp014943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lennon V. A., Lambert E. H. Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin Proc. 1989 Dec;64(12):1498–1504. doi: 10.1016/s0025-6196(12)65705-x. [DOI] [PubMed] [Google Scholar]
  6. Leys K., Lang B., Johnston I., Newsom-Davis J. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann Neurol. 1991 Mar;29(3):307–314. doi: 10.1002/ana.410290313. [DOI] [PubMed] [Google Scholar]
  7. Llinás R. R. The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function. Science. 1988 Dec 23;242(4886):1654–1664. doi: 10.1126/science.3059497. [DOI] [PubMed] [Google Scholar]
  8. Miller R. J. Multiple calcium channels and neuronal function. Science. 1987 Jan 2;235(4784):46–52. doi: 10.1126/science.2432656. [DOI] [PubMed] [Google Scholar]
  9. Newsom-Davis J., Murray N. M. Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome. Neurology. 1984 Apr;34(4):480–485. doi: 10.1212/wnl.34.4.480. [DOI] [PubMed] [Google Scholar]
  10. O'Neill J. H., Murray N. M., Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain. 1988 Jun;111(Pt 3):577–596. doi: 10.1093/brain/111.3.577. [DOI] [PubMed] [Google Scholar]
  11. Oguro-Okano M., Griesmann G. E., Wieben E. D., Slaymaker S. J., Snutch T. P., Lennon V. A. Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma. Mayo Clin Proc. 1992 Dec;67(12):1150–1159. doi: 10.1016/s0025-6196(12)61144-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES